Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA 5-FU CTRPv2 pan-cancer AAC -0.04 0.2
mRNA Merck60 CTRPv2 pan-cancer AAC 0.036 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.3
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.043 0.3
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.038 0.3
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
Download CSV